Abstract
Kawasaki's disease is an acute systemic vasculitic syndrome that primarily affects children. Coronary aneurysms are common vasculitic sequelae of Kawasaki's disease. Intracoronary thrombosis and embolization are potential consequences of coronary aneurysms. We describe our experience of successful thrombolysis using the combination of reduced-dose intravenous tissue plasminogen activator and abciximab as described in the Thrombolysis in Myocardial Infarction 14 trial (TIMI 14) to treat a patient found to have intracoronary thrombus at the site of aneurysm formation due to Kawasaki's disease.
Original language | English (US) |
---|---|
Pages (from-to) | 651-653 |
Number of pages | 3 |
Journal | Journal of Invasive Cardiology |
Volume | 13 |
Issue number | 9 |
State | Published - Sep 2001 |
Keywords
- Coronary aneurysm
- Glycoprotein IIb/IIIa inhibitors
- Thrombolytics
ASJC Scopus subject areas
- General Medicine